Laboratory parameters in patients randomized in the stop study and their modification by transfusion

A. Kutlar; J. Harbin; B. Jackson; L. Holley; D. Gallagher; B. Clair; D. Brambilla; R. Adams; V. McKie; L. Hsu; B. Files; E. Vichinsky; C. Pegelow; M. Abboud; G. Woods; N. Olivieri; C. Driscoll; S. Miller; W. Wang; S. Piomelli; C. Scher; B. Berman

Laboratory parameters in patients randomized in the stop study and their modification by transfusion

A. Kutlar, J. Harbin, B. Jackson, L. Holley, D. Gallagher, B. Clair, D. Brambilla, R. Adams, V. McKie, L. Hsu, B. Files, E. Vichinsky, C. Pegelow, M. Abboud, G. Woods, N. Olivieri, C. Driscoll, S. Miller, W. Wang, S. PiomelliC. Scher, B. Berman

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

The STOP study was the first randomized trial of primary stroke prevention in sickle cell disease (Hb SS). 130 Hb SS children, age 2-16, at risk for stroke by Transcranial Doppier (TCD) were randomized to standard care (STC) (n=67) or transfusion (Tx)(n=63). There were no significant clinical or hématologie differences between the two groups except for a lower Hb (7.2 vs 7.6 g/dl, p=.001 ) and Hct (20.4 vs 21.7%, p=.002) in the Tx arm. Tx arm patients (transfused every 3-4 weeks to maintain Hb S

Original language	English (US)
Journal	Blood
Volume	96
Issue number	11 PART II
State	Published - 2000
Externally published	Yes

ASJC Scopus subject areas

Hematology

Cite this

Kutlar, A., Harbin, J., Jackson, B., Holley, L., Gallagher, D., Clair, B., Brambilla, D., Adams, R., McKie, V., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Woods, G., Olivieri, N., Driscoll, C., Miller, S., Wang, W., ... Berman, B. (2000). Laboratory parameters in patients randomized in the stop study and their modification by transfusion. Blood, 96(11 PART II).

Kutlar, A, Harbin, J, Jackson, B, Holley, L, Gallagher, D, Clair, B, Brambilla, D, Adams, R, McKie, V, Hsu, L, Files, B, Vichinsky, E, Pegelow, C, Abboud, M, Woods, G, Olivieri, N, Driscoll, C, Miller, S, Wang, W, Piomelli, S, Scher, C & Berman, B 2000, 'Laboratory parameters in patients randomized in the stop study and their modification by transfusion', Blood, vol. 96, no. 11 PART II.

@article{7a3a2640e0e5465a8de68579024820bd,

title = "Laboratory parameters in patients randomized in the stop study and their modification by transfusion",

abstract = "The STOP study was the first randomized trial of primary stroke prevention in sickle cell disease (Hb SS). 130 Hb SS children, age 2-16, at risk for stroke by Transcranial Doppier (TCD) were randomized to standard care (STC) (n=67) or transfusion (Tx)(n=63). There were no significant clinical or h{\'e}matologie differences between the two groups except for a lower Hb (7.2 vs 7.6 g/dl, p=.001 ) and Hct (20.4 vs 21.7%, p=.002) in the Tx arm. Tx arm patients (transfused every 3-4 weeks to maintain Hb S ",

author = "A. Kutlar and J. Harbin and B. Jackson and L. Holley and D. Gallagher and B. Clair and D. Brambilla and R. Adams and V. McKie and L. Hsu and B. Files and E. Vichinsky and C. Pegelow and M. Abboud and G. Woods and N. Olivieri and C. Driscoll and S. Miller and W. Wang and S. Piomelli and C. Scher and B. Berman",

year = "2000",

language = "English (US)",

volume = "96",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "11 PART II",

}

TY - JOUR

T1 - Laboratory parameters in patients randomized in the stop study and their modification by transfusion

AU - Kutlar, A.

AU - Harbin, J.

AU - Jackson, B.

AU - Holley, L.

AU - Gallagher, D.

AU - Clair, B.

AU - Brambilla, D.

AU - Adams, R.

AU - McKie, V.

AU - Hsu, L.

AU - Files, B.

AU - Vichinsky, E.

AU - Pegelow, C.

AU - Abboud, M.

AU - Woods, G.

AU - Olivieri, N.

AU - Driscoll, C.

AU - Miller, S.

AU - Wang, W.

AU - Piomelli, S.

AU - Scher, C.

AU - Berman, B.

PY - 2000

Y1 - 2000

N2 - The STOP study was the first randomized trial of primary stroke prevention in sickle cell disease (Hb SS). 130 Hb SS children, age 2-16, at risk for stroke by Transcranial Doppier (TCD) were randomized to standard care (STC) (n=67) or transfusion (Tx)(n=63). There were no significant clinical or hématologie differences between the two groups except for a lower Hb (7.2 vs 7.6 g/dl, p=.001 ) and Hct (20.4 vs 21.7%, p=.002) in the Tx arm. Tx arm patients (transfused every 3-4 weeks to maintain Hb S

AB - The STOP study was the first randomized trial of primary stroke prevention in sickle cell disease (Hb SS). 130 Hb SS children, age 2-16, at risk for stroke by Transcranial Doppier (TCD) were randomized to standard care (STC) (n=67) or transfusion (Tx)(n=63). There were no significant clinical or hématologie differences between the two groups except for a lower Hb (7.2 vs 7.6 g/dl, p=.001 ) and Hct (20.4 vs 21.7%, p=.002) in the Tx arm. Tx arm patients (transfused every 3-4 weeks to maintain Hb S

UR - http://www.scopus.com/inward/record.url?scp=33748107053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748107053&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33748107053

SN - 0006-4971

VL - 96

JO - Blood

JF - Blood

IS - 11 PART II

ER -

Laboratory parameters in patients randomized in the stop study and their modification by transfusion

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this